GASTRODUODENAL BLEEDING, ETIOPATHOGENESIS, DIAGNOSIS AND PREVENTION OF RESIDENTS

Abstract

Among the population, 11-14% of men and 8-11% of women may develop gastroduodenal ulcer disease during their lives, which in 15-20% of patients is complicated by ulcerative bleeding. In this case, methods of local influence on the ulcerative defect are used through a fibrogastroendoscope with the introduction of drugs directly into the area of the ulcerative defect using injection and application methods or electrohemostasis. However, their range of effects on the processes of hemostasis and regeneration is extremely narrow. There is evidence that the rate of recurrent bleeding after isolated local use of vasoconstrictors reaches 16.7% - 24.1%. In this connection, the development of effective methods of endoscopic hemostasis for ulcerative gastroduodenal bleeding remains an urgent clinical problem.